Manish Bhandari’s Vallum Capital has delivered a splendid performance in FY 2016-17 with 51% gain. He has discussed his portfolio of stocks and also identified new stock picks with multibagger potential
Posts tagged Shilpa Medicare
Rakesh Jhunjhunwala’s Fav Multibagger...
Rakesh Jhunjhunwala’s favourite stock, which has already delivered magnificent gains of nearly 700% to his portfolio, is presently in the doldrums. Leading experts have opined that the stock is a “strong buy” now and that hefty gains can be reaped from it
Model Portfolio Of 17 Multibagger Sto...
17 eminent stock wizards have recommended 17 top-quality stocks with the confident assurance that the stocks have multibagger potential and will fill our portfolios with mega gains
16 Potential Multibagger Stocks Spark...
Raamdeo Agrawal and his ace team at Motilal Oswal never disappoint novice investors. In his latest 21st Wealth Creation Study, Raamdeo has not only tutored us on the theoretical aspects of finding multibagger stocks but has also given us a ready-made sample portfolio of 16 top-quality stocks to play with
Best Multibagger Stocks To Buy For 20...
Four well-known stock pickers, with a proven track record for finding multibagger stocks, have recommended 17 top-quality stocks for investment with the solemn assurance that the stocks will sparkle and shower hefty gains on investors
Fav “Pole Position” Stock Of Dolly Kh...
When four eminent stock pickers of proven caliber declare confidence in a stock, more research is not required to be done because it is certain that hefty gains will gush out of the stock sooner or later. Nevertheless, leading experts have analyzed the stock and confirmed that it is indeed a good buy
Motilal Oswal Downgrades Raamdeo Agra...
Raamdeo Agrawal, the boss man of Motilal Oswal, recommended a stock on the basis that it has a huge “competitive advantage” and other stellar virtues. Unfortunately, the stock now faces the ignominy of being downgraded by Motilal Oswal itself owing to “competitive pressures ”
Forget Lottery Tickets, Buy Pharma St...
Pharma stocks have lost favour amongst investors owing to the USFDA regulatory headwinds. However, this is the opportune time to buy these stocks because they have several years of strong growth in them say Rakesh Jhunjhunwala and Raamdeo Agrawal
Manish Bhandari Of Vallum Rakes In 11...
Manish Bhandari’s PMS has reported a spectacular performance with some stocks blowing off the ceiling with up to 11x gains in just 18 months. He has also announced the addition of new stocks to the portfolio, which we have to keep an eagle eye on
Daljeet Kohli Condemns Fav Contra Sto...
A mid-cap Pharma stock strongly recommended by Sanjoy Bhattacharyya & Saurabh Mukherjea is facing the ignominy of being declared a flop. Luckily, another “100 Bagger” Pharma stock is surging and bringing cheer to investors
Recent Comments